Dauricine suppressed the angiogenesis in human breast cancer by suppressing the expression of vascular endothelial growth factor and the accumulation of hypoxia-inducible factor 1α (HIF-1α) protein [63]. The gene discussed is HIF1A; the disease is breast cancer.